Thanks for the reply. I've found this article https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30211-7/fulltext that reports in Wuhan Jinyintan Hospital (Jan 1-20, 2020) out of 78 covid-19 patients with pneumonia 0 of them were co-infected with the other viruses that were tested for. They tested for nine respiratory pathogens and influenza A and B.
But take a look at this article from the Qingdao Women and Children’s Hospital https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3550013 . Among covid-19 patients in Qingdao, 24 (80.00%) of them had IgM antibodies against at least one respiratory pathogen, whereas only one (2.60%) of the patients in Wuhan had positive results for serum IgM antibody detection ( P <0.0001). The most common respiratory pathogens detected in Qingdao covid-19 patients were influenza virus A (60.00%) and influenza virus B (53.30%), followed by mycoplasma pneumoniae (23.30%) and legionella pneumophila (20.00%).
And take a look at this article out of Iran https://www.preprints.org/manuscript/202003.0291/v1. They selected 4 patients who presented with pneumonia symptoms and were suspicious for covid-19 and referred them to the intended centers for covid-19 diagnosis and management of Shiraz University of Medical Sciences in the south of Iran. All 4 of them were diagnosed with co-infection of covid-19 and influenza virus.
It seems like the patients in Wuhan had much lower rates of co-infection than patients outside of Wuhan, and that co-infection is very common outside of Wuhan. How can we explain this?